Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00208741 · ClinicalTrials.gov registry record · Phase 4

Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder

A Phase 4 study of Social Anxiety Disorder, sponsored by Emory University.

Completed
Registry status
Phase 4
Development phase
50
Enrollment target
3
Study locations

NCT00208741 is a Phase 4 study of Social Anxiety Disorder that has completed, run by Emory University. The registered enrollment target is 50 participants, below the 159-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (69% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00208741, a Phase 4 study of Social Anxiety Disorder, has completed, sponsored by Emory University.

COMPLETED
Registry status
Phase 4
Development phase
50 participants
Enrollment target
3
Study locations

Study Summary

The main purpose of this study is to determine how safe and effective Gabitril is for outpatients with Social Anxiety Disorder (SAD).

Conditions Studied

Social Anxiety Disorder

Interventions

  • DRUG Gabitril

Study Locations (3)

New York

  • Hillside Hospital of the North Shore-Long Island Jewish Health System - Long Island City
  • Columbia/New York State Psychiatric Institute - New York

Georgia

  • Emory University School of Medicine - Atlanta

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2002-06
Est. Completion 2003-11
Phase Phase 4

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00208741

The ClinicalTrials.gov registry entry for NCT00208741 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 159-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (69% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Social Anxiety Disorder appearing as the primary indexed condition, and to 1 intervention - of which Gabitril is the first listed.

NCT00208741 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Georgia.

Frequently Asked Questions

What is clinical trial NCT00208741 about?

NCT00208741 is a clinical study titled "Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder". The main purpose of this study is to determine how safe and effective Gabitril is for outpatients with Social Anxiety Disorder (SAD).

What is the current status of trial NCT00208741?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2002-06. Estimated completion is 2003-11.

What conditions does trial NCT00208741 study?

This clinical trial studies the following conditions: Social Anxiety Disorder.

What interventions are being tested in trial NCT00208741?

The interventions under investigation include: Gabitril (DRUG).

Who is sponsoring clinical trial NCT00208741?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00208741 being conducted?

This trial has 3 study locations across Georgia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Social Anxiety Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Social Anxiety Disorder

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.